Adtalem Global Ed Inc Stock Price, News & Analysis

Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the US, has appointed Megan Noel as its new Chief Corporate Affairs Officer, effective immediately. Noel, a recognized corporate affairs leader with two decades of experience, will oversee communications, investor relations, government relations, and impact and alumni engagement. She will manage stakeholder relationships across Adtalem's portfolio, engaging with 10,000 employees, 94,000 students, and 350,000 alumni.

Noel joins from Golin, where she served as global president of corporate affairs. Her previous experience includes leading communications and corporate affairs for PwC US and Mexico, and nine years at Edelman. A Georgetown University graduate, Noel has received recognition as a Top Woman in PR and PR Week 40 under 40 recipient.

Adtalem Global Education (NYSE: ATGE) reported strong third quarter fiscal 2025 results, with total enrollment reaching 94,223 students, up 9.8% year-over-year. Revenue increased 12.9% to $466.1 million, while adjusted EPS grew 28% to $1.92. The company's key segments showed robust growth, with Chamberlain University achieving its ninth straight quarter of enrollment growth (+6.8%) and Walden University posting its seventh consecutive quarter of growth (+13.5%).

Notable achievements include a 95% first-time residency attainment rate for medical graduates and completion of a $300 million share repurchase program. The company announced a new $150 million share repurchase authorization through May 2028. Given strong performance, Adtalem raised its fiscal year 2025 guidance, projecting revenue of $1,760-1,775 million and adjusted EPS of $6.40-6.60.

Adtalem Global Education (NYSE: ATGE), the leading US healthcare educator, has announced a new $150 million share repurchase program through May 2028. The company has also completed its previous $300 million share repurchase program ahead of schedule, which was originally authorized through January 2027.

Since February 2022, Adtalem has returned $763 million to shareholders, reducing outstanding shares by 28% at an average price of approximately $49 per share. The company currently has about 36 million shares outstanding as of May 5, 2025. The new repurchases will be funded through available cash and operating cash generation, with timing and amount determined based on market conditions.

Adtalem Global Education (NYSE: ATGE) announced a 95% first-time residency attainment rate for 2024-2025 graduates from its medical schools, American University of the Caribbean School of Medicine (AUC) and Ross University School of Medicine (RUSM). This marks the fourth consecutive year achieving at least 95%.

Over 615 students and graduates will train across 42 U.S. states and territories in 26 specialties, with more than 130 matching into partner clinical hospitals. Notably, over 40% of placements will train in medically underserved areas, with more than 450 students matching into primary care residencies.

The placement results highlight significant diversity metrics: 173 students identify as Black/African American or Hispanic, and more than 385 female students secured residency placements. The program includes over 100 matches in Emergency Medicine and various competitive specialties like Internal Medicine/Pediatrics, Obstetrics and Gynecology, and Orthopedic Surgery.

Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the United States, has scheduled its third quarter fiscal year 2025 earnings release and conference call. The company will announce its financial results on Thursday, May 8, 2025, after market close.

A conference call to discuss the results will be held the same day at 4:00 p.m. CT (5:00 p.m. ET). Participants can join via phone or through a simulcast on the company's investor relations website. A replay will be available for 30 days through both phone access and the website.

Chamberlain University, an Adtalem Global Education (NYSE: ATGE) institution and the largest nursing school in the country, has appointed Mary Beth Kingston, PhD, RN, FAAN, as chair of its board of trustees. Kingston, a 2024 AONL Lifetime Achievement Award recipient, brings over 40 years of healthcare industry experience to the role.

Kingston previously served as Executive Vice President and Chief Nursing Officer for Advocate Health, managing nursing strategy and operations. Her notable achievements include being named among Modern Healthcare's 50 Most Influential Clinical Executives in 2021, 2023, and 2024, and becoming a fellow of the American Academy of Nursing in 2020.

Adtalem Global Education (NYSE: ATGE), the leading healthcare educator in the United States, has announced its participation in the Barclays 27th Annual Global Healthcare Conference in Miami, Florida on March 11. Chairman and CEO Steve Beard, along with Senior VP and CFO Bob Phelan, will be attending the conference.

The company, focused on addressing the nationwide healthcare provider shortage, implements strategic investments to enhance educational access, student experience, and outcomes. Interested parties can schedule one-on-one meetings with management through their Barclays representative.

Chamberlain University and the Oncology Nursing Society (ONS) have launched a free 16-week Introduction to Oncology Nursing course as part of the Practice Ready. Specialty Focused.™ (PRSF) initiative. The program, funded by the American Nurses Foundation, aims to address the national nursing shortage by providing pre-licensure students with specialized healthcare training.

The course is available online and across all 23 Chamberlain campuses, offering four modules: Cancer Basics, Cancer Treatment Modalities, Symptom Management, and Cancer Treatment and Beyond. From January 2022 through May 2024, the PRSF program has enrolled 2,263 students with a 90% completion rate. Additional PRSF courses include emergency nursing, perioperative, home health nursing, nephrology, and critical care nursing.

Adtalem Global Education (ATGE) reported strong Q2 FY2025 results with significant growth across key metrics. Total enrollment reached 91,264, up 11.6% year-over-year, while revenue increased 13.9% to $447.7 million. The company achieved diluted earnings per share of $1.98 and adjusted EPS of $1.81, representing 47.2% growth.

Notable highlights include Chamberlain University's eighth consecutive quarter of enrollment growth (up 11.5%) and Walden University's sixth straight quarter of growth (up 13.2%). The company demonstrated strong financial management by repurchasing $38 million in shares and repaying $100 million of Term Loan B.

Based on these results, Adtalem raised its FY2025 guidance, projecting revenue between $1,730-$1,760 million and adjusted earnings per share of $6.10-$6.30, representing growth of 21.5-25.5% year-over-year.